Prosecution Insights
Last updated: July 17, 2026
Application No. 18/138,017

SYSTEMS AND METHODS FOR MOBILE DEVICE ANALYSIS OF NUCLEIC ACIDS AND PROTEINS

Non-Final OA §102
Filed
Apr 21, 2023
Priority
Mar 15, 2013 — provisional 61/790,354 +4 more
Examiner
PRIEST, AARON A
Art Unit
1681
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Nanobiosym Inc.
OA Round
1 (Non-Final)
61%
Grant Probability
Moderate
1-2
OA Rounds
0m
Est. Remaining
87%
With Interview

Examiner Intelligence

Grants 61% of resolved cases
61%
Career Allowance Rate
488 granted / 800 resolved
+1.0% vs TC avg
Strong +26% interview lift
Without
With
+25.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
42 currently pending
Career history
830
Total Applications
across all art units

Statute-Specific Performance

§101
3.5%
-36.5% vs TC avg
§103
47.3%
+7.3% vs TC avg
§102
12.5%
-27.5% vs TC avg
§112
11.7%
-28.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 800 resolved cases

Office Action

§102
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . DETAILED ACTION Status of the Claims Claim 1 is pending and the subject of this NON-FINAL Office Action. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. § 102 that form the basis for the rejections under this section made in this Office action: (a)Novelty; Prior Art.—A person shall be entitled to a patent unless— (1)the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention; or (2)the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1 is rejected under 35 U.S.C. § 102(a)(2) as being anticipated by BASHIR (US20140363821). As to claim 1, BASHIR teaches a system for rapid analysis of biological samples, comprising: a mobile device that receives at least one integrated chip (e.g. paras. 0006 & 0035); the mobile device processing the integrated chip to analyze a biological sample loaded thereon (id.); the mobile device and the integrated chip together being configured to perform at least one of manipulation and control of a molecule or a fluidic system on the integrated chip (id.); and wherein the mobile device and integrated chip together are configured to precision control at least one parameter that governs at least one of a plurality of steps of the analysis of the biological sample to within plus or minus 10%, plus or minus 1% (para. 0013; “In an aspect, the minimum temperature in the fluid droplet for any of the methods and devices provided herein is substantially equal to the temperature of the gas phase atmosphere that surrounds the fluid droplet. “Substantially equal” in this aspect refers to temperatures that are within about 10%, within about 5%, or within about 1% of each other.”). It is also noted that “the mobile device processing the integrated chip to analyze a biological sample loaded thereon” merely states an intended use of the claimed system and fails to further define the system. Claims 1 is rejected under 35 U.S.C. § 102(a)(1) as being anticipated by FORET (US20020157951). As to claim 1, FORET teaches a system for rapid analysis of biological samples, comprising: a mobile device that receives at least one integrated chip (portable microchip, which requires device to process it; e.g. paras. 0008, 0021-22); the mobile device processing the integrated chip to analyze a biological sample loaded thereon (id.); the mobile device and the integrated chip together being configured to perform at least one of manipulation and control of a molecule or a fluidic system on the integrated chip (id.); and wherein the mobile device and integrated chip together are configured to precision control at least one parameter that governs at least one of a plurality of steps of the analysis of the biological sample to within plus or minus 0.0001% (e.g. para. 0008; “Using the system of the invention, a run temperature can remain stable to within 0.01-0.02°C” yields, for example, 0.01/100°C=0.0001% stable). It is also noted that “the mobile device processing the integrated chip to analyze a biological sample loaded thereon” merely states an intended use of the claimed system and fails to further define the system. Conclusion No claims are allowed. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Aaron Priest whose telephone number is (571)270-1095. The examiner can normally be reached 8am-6pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Gary Benzion can be reached on (571) 272-0782. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /AARON A PRIEST/Primary Examiner, Art Unit 1681
Read full office action

Prosecution Timeline

Apr 21, 2023
Application Filed
Nov 07, 2024
Non-Final Rejection mailed — §102
May 07, 2025
Response Filed
May 07, 2025
Response after Non-Final Action
Feb 06, 2026
Response Filed

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12668836
DETECTION OF RECOMBINASE POLYMERASE AMPLIFICATION (RPA) AMPLICONS VIA FEN1 CLEAVAGE
5y 1m to grant Granted Jun 30, 2026
Patent 12669632
DEVICES AND COMPOSITIONS FOR USE IN LUMINESCENT IMAGING OF MULTIPLE SITES WITHIN A PIXEL, AND METHODS OF USING THE SAME
3y 5m to grant Granted Jun 30, 2026
Patent 12668833
METHODS, SYSTEMS, AND COMPOSITIONS FOR COUNTING NUCLEIC ACID MOLECULES
2y 9m to grant Granted Jun 30, 2026
Patent 12664653
CAPTURE CONSTRUCT AND METHOD FOR DETECTING A PLURALITY OF ANALYTES
2y 8m to grant Granted Jun 23, 2026
Patent 12655486
COMPOSITIONS AND METHODS FOR DETECTING PLASMODIUM SPECIES NUCLEIC ACID
4y 7m to grant Granted Jun 16, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
61%
Grant Probability
87%
With Interview (+25.9%)
3y 2m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 800 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month